Edition:
United Kingdom

Shire PLC (SHP.L)

SHP.L on London Stock Exchange

4,690.00GBp
7 Jan 2019
Change (% chg)

0.00 (+0.00%)
Prev Close
4,690.00
Open
4,690.00
Day's High
4,690.00
Day's Low
4,690.00
Volume
0
Avg. Vol
4,532,743
52-wk High
4,827.75
52-wk Low
2,940.50

Select another date:

Mon, Jan 7 2019

Photo

Takeda unlikely to sell OTC drug business: CEO

TOKYO Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it closes a $59 billion takeover of London-listed Shire , Chief Executive Christophe Weber said on Monday.

Takeda unlikely to sell OTC drug business -CEO

TOKYO, Jan 7 Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it closes a $59 billion takeover of London-listed Shire, Chief Executive Christophe Weber said on Monday.

UPDATE 4-Takeda clears key hurdle as investors back $59 billion Shire deal

* Shares in Shire and Takeda both gain ground (Updates with approval from Shire shareholders)

Takeda shareholders approve Shire acquisition - spokesman

TOKYO, Dec 5 Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire, a Takeda spokesman said, creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt.

Investor advisory firms back Takeda's $62 billion deal for Shire

LONDON Two shareholder advisory firms have backed Takeda Pharmaceutical's $62 billion (48 billion pounds) takeover offer for drugmaker Shire , dealing a blow to a group of investors who hope to block the deal.

EU approves Takeda buying Shire, on divestment condition

BRUSSELS The European Commission said on Tuesday that it approved the $62-billion (48.2 billion pounds) takeover of London's Shire plc by Takeda Pharmaceutical of Japan, subject to the divestment of a Shire drug in development.

EU mergers and takeovers (Nov 20)

BRUSSELS, Nov 20 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

EU approves Takeda buying Shire, on divestment condition

BRUSSELS The European Commission said on Tuesday that it approved the $62-billion takeover of London's Shire plc by Takeda Pharmaceutical of Japan, subject to the divestment of a Shire drug in development.

EU approves Takeda buying Shire, on divestment condition

BRUSSELS, Nov 20 The European Commission said on Tuesday that it approved the $62-billion takeover of London's Shire plc by Takeda Pharmaceutical of Japan, subject to the divestment of a Shire drug in development.

Investor advisory firms back Takeda's $62 billion deal for Shire

LONDON Two shareholder advisory firms have backed Takeda Pharmaceutical's $62 billion takeover offer for drugmaker Shire , dealing a blow to a group of investors who hope to block the deal.

Select another date: